MUC16 and ovarian cancer: However, CA125 is neither specific nor sensitive as a diagnostic marker for ovarian cancer because it is found to be elevated in gynecological benign diseases affecting pre-menopausal women as well as in conditions such as liver cirrhosis and heart failure, thereby limiting its applicability as a biomarker for OvCa [4,15,17,18].